These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 5473222)
21. [Atherosclerosis and Regelan]. Schwaar R Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569 [No Abstract] [Full Text] [Related]
22. [Humoral lipid and protein changes in reducing therapy of obesity]. Dumitrescu C; Mihalache N Stud Cercet Endocrinol; 1968; 19(5):417-23. PubMed ID: 5716146 [No Abstract] [Full Text] [Related]
23. [Action mechanism and clinical success of Regelan (Clofibrate)]. Fitzgerald JD Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437 [No Abstract] [Full Text] [Related]
24. Effect of clofibrate on serum and hepatic lipids in nephrotic rats. Hoak JC; Connor WE; Armstrong ML; Warner ED Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117 [No Abstract] [Full Text] [Related]
25. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate). Braunsteiner H; Herbst M; Sandhofer F; Sailer S Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144 [No Abstract] [Full Text] [Related]
26. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids]. Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979 [No Abstract] [Full Text] [Related]
27. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases]. Warembourg H; Jaillard J Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637 [No Abstract] [Full Text] [Related]
28. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions. Turazza G; Spreafico PL; Frandoli G Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777 [No Abstract] [Full Text] [Related]
29. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies. Vannas S; Esilä R; Tuovinen E Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673 [No Abstract] [Full Text] [Related]
30. A comparison of platelet stickiness tests during an atromid-S trial. O'Brien JR; Heywood JB Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687 [No Abstract] [Full Text] [Related]
31. [Effect of clofibrate on serum lipids in atherosclerosis]. Gietz E Med Klin; 1967 Mar; 62(9):336-8 passim. PubMed ID: 5593571 [No Abstract] [Full Text] [Related]
32. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate). Oliver MF Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747 [No Abstract] [Full Text] [Related]
33. [CPIB: a hypolipidemic agent. Study of 20 patients]. Verdy M Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817 [No Abstract] [Full Text] [Related]
34. [Studies on the interrelations between blood clotting in the thromboelestographic picture and the total lipid, beta-lipoprotein and cholesterol level and the degree of lipemic turbidity of the serum]. Zola-Sleczek E; Kieta-Fyda A Pol Tyg Lek; 1967 Feb; 22(9):321-4. PubMed ID: 6081994 [No Abstract] [Full Text] [Related]
35. Clofibrate in perspective. N Engl J Med; 1968 Oct; 279(16):885-6. PubMed ID: 5677725 [No Abstract] [Full Text] [Related]
36. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. Best MM; Duncan CH Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616 [No Abstract] [Full Text] [Related]
37. Foam cells in the renal glomerulus. McKenzie IF; Kincaid-Smith P J Pathol; 1969 Jan; 97(1):151-4. PubMed ID: 5783631 [No Abstract] [Full Text] [Related]